Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 11;4(2):436-451.
doi: 10.1021/acsptsci.1c00024. eCollection 2021 Apr 9.

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review

Richard J Zeifman  1 , Nikhita Singhal  2 , Leah Breslow  3 , Cory R Weissman  2
Affiliations
Review

On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review

Richard J Zeifman et al. ACS Pharmacol Transl Sci. .

Erratum in

Abstract

Use of classic psychedelics (e.g., psilocybin, ayahuasca, and lysergic acid diethylamide) is increasing, and psychedelic therapy is receiving growing attention as a novel mental health intervention. Suicidality remains a potential safety concern associated with classic psychedelics and is, concurrently, a mental health concern that psychedelic therapy may show promise in targeting. Accordingly, further understanding of the relationship between classic psychedelics and suicidality is needed. Therefore, we conducted a systematic review of the relationship between classic psychedelics (both non-clinical psychedelic use and psychedelic therapy) and suicidality. We identified a total of 64 articles, including 41 articles on the association between non-clinical classic psychedelic use and suicidality and 23 articles on the effects of psychedelic therapy on suicidality. Findings on the association between lifetime classic psychedelic use and suicidality were mixed, with studies finding positive, negative, and no significant association. A small number of reports of suicide and decreased suicidality following non-clinical classic psychedelic use were identified. Several cases of suicide in early psychedelic therapy were identified; however, it was unclear whether this was due to psychedelic therapy itself. In recent psychedelic therapy clinical trials, we found no reports of increased suicidality and preliminary evidence for acute and sustained decreases in suicidality following treatment. We identify some remaining questions and provide suggestions for future research on the association between classic psychedelics and suicidality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. dos Santos R. G.; Hallak J. E. C. (2019) Ayahuasca, an Ancient Substance with Traditional and Contemporary Use in Neuropsychiatry and Neuroscience. Epilepsy Behav 106300.10.1016/j.yebeh.2019.04.053. - DOI - PubMed
    1. Nichols D. E. (2016) Psychedelics. Pharmacol. Rev. 68 (2), 264–355. 10.1124/pr.115.011478. - DOI - PMC - PubMed
    1. Nour M. M.; Carhart-Harris R. L. (2017) Psychedelics and the Science of Self-experience. Br. J. Psychiatry 210 (3), 177–179. 10.1192/bjp.bp.116.194738. - DOI - PubMed
    1. Carhart-Harris R. L.; Erritzoe D.; Haijen E.; Kaelen M.; Watts R. (2018) Psychedelics and Connectedness. Psychopharmacology 235 (2), 547–550. 10.1007/s00213-017-4701-y. - DOI - PubMed
    1. James E.; Robertshaw T. L.; Hoskins M.; Sessa B. (2020) Psilocybin Occasioned Mystical-Type Experiences. Hum. Psychopharmacol. 35 (5), e2742.10.1002/hup.2742. - DOI - PubMed

LinkOut - more resources